MilliporeSigma and genOway enter CRISPR collaboration
genOway has acquired exclusive rights to MilliporeSigma's genome-editing patents to produce and sell new rodent models.
Archives for December 19, 2018
Alnylam settles ‘inherently unpredictable’ patent litigation over Onpattro
Alnylam settled its patent litigation with Silence Therapeutics, after an ongoing litigation regarding patent infringement of Silence’s RNAi therapy.
Watch out for the ‘scale and speed’ of transformation in China, says Sanofi exec
Transformation in cell therapies is happening at an even faster rate than the US, suggests Christoph Heinemann of Sanofi.
Pfizer wins EMA positive opinion for Avastin biosimilar
The EMA has recommended approval of Pfizer’s Zirabev, a proposed biosimilar to Roche’s Avastin.